$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Personalized choice of cabergoline administration time
2026-02-01 22:25:32
Check Details
Reasons why cabergoline is not marketed in China
2026-02-01 22:25:32
Check Details
Detailed explanation of the market situation and prices of generic cabergoline drugs
2026-02-01 22:25:32
Check Details
Cabergoline’s pharmacological effects and multiple clinical applications
2026-02-01 22:25:32
Check Details
Restrictions on the use of cabergoline and those who should use it with caution
2026-02-01 22:25:32
Check Details
Molotinib (Ojjaara) use restrictions and high-risk groups
2026-02-01 22:25:32
Check Details
A brief description of the pharmacological characteristics and therapeutic applications of molotinib (Ojjaara)
2026-02-01 22:25:32
Check Details
Molotinib (Ojjaara) efficacy and potential side effects
2026-02-01 22:25:32
Check Details
Molotinib medication guide for the treatment of myelofibrosis
2026-02-01 22:25:32
Check Details
A detailed explanation of the potential side effects of molotinib (Ojjaara)
2026-02-01 22:25:32
Check Details
How much does a box of Serpatinib cost in 2024?
2026-02-01 22:25:32
Check Details
Latest Price of Serpatinib in 2024
2026-02-01 22:25:32
Check Details
1
2
...
837
838
839
840
841
842
843
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
2
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
3
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
4
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
5
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
6
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB
7
Pacritinib Drug Contraindications and Precautions
8
Pomalidomide Side Effects, Risk Monitoring, and Precautions
9
Dasatinib for Ph+ Chronic Myeloid Leukemia: Dosage, Administration, and Long-Term Care
10
Obeticholic Acid 5 mg for PBC: Dosage, Risks, and Current Status
11
Acalabrutinib Monotherapy for CLL: What It Can and Cannot Do
12
Bepirovirsen for Chronic HBV Functional Cure: FDA Criteria and B-Well Data